secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2026-07-07T21:24:32+00:00
Accession:  0001193125-26-297658
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed sells MatrixCare to Frazier Healthcare for $490M cash; sharpens focus on sleep health
--------------------------------------------------------------------------------

- All-cash deal valued at $490M, subject to closing adjustments; expected to close in Q1 FY2027.
- MatrixCare had ~$220M revenue and ~$55M non-GAAP operating profit in FY2026.
- Net proceeds to be used for share repurchases (ASR) and general corporate purposes.
- Noctrix acquisition expected to add ~$30M revenue but reduce non-GAAP diluted EPS by ~$0.20 in FY2027.
- ResMed reiterates FY2026 non-GAAP margin, SG&A, R&D, and tax rate outlook; full FY2027 guidance on Aug 6 call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312526297658/0001193125-26-297658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312526297658/d88958d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-297658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer